Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Pembacaan Jurnal: Deep Vein Thrombosis: A Clinical Review

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 22

Pembacaan Jurnal :

Deep vein thrombosis: a clinical review

Oleh : Aswin Yusuf

Pembimbing Residen :
Dr.Kenny Edward Yap

Konsulen Pembimbing :
dr. Rosie, Sp.BTKV

Dibawakan Dalam Rangka Kepaniteraan Klinik


Departemen Ilmu Bedah
Fakultastas Kedokteran
Universitas Hasanuddin
 The term thrombosis refers to the formation,
from constituents of blood, of an abnormal
mass within the vascular system of a living
animal.
 When this process occurs within the deep
veins, it is referred to as deep vein
thrombosis (DVT).
 DVT is a major and a common preventable
cause of death worldwide.
 It affects approximately 0.1% of persons per
year.
 The overall average age- and sex-adjusted
annual incidence of venous
thromboembolism (VTE) is 117 per 100,000
(DVT, 48 per 100,000; PE, 69 per 100,000),
 DVT in the lower limb can be classified as
a) proximal, when the popliteal vein or thigh
veins are involved
b) distal, when the calf veins are involved
• starts in the valve pocketsof
the veins
Thrombus • This is especially true for
those that occur following
formation surgery.

• increased expression of
endothelial protein C
origin of receptor (EPCR) and
thrombomodulin (TM)
thrombus • decreased expression of Von
Willebrand factor (vWF) n
Manifestasi Klinis

1. History and clinical


examination are not 1. Homans’ sign
reliable may be 1. The left leg
2. Lower extremity demonstrable in :Pregnancy and
DVT can be acute massive
DVT
symptomatic venous thrombosis
or asymptomatic. 2. lack specificity
Predispose
to thrombus, endot
helial
injury
Rudolph
Virchow :
Virchow’s
triad stasis or
blood turbulenc
hypercoa e of
gulability blood
flow
Risk :acquired or
genetic

risk of VTE that


exceeds the
acquired genetic separate
effects of a
single factor
Clinical model : Wells and
colleagues
High -
Low - moderate- probability
probability probability
Groups :
Groups : Groups : 85% risk of
5% risk 33% risk
DVT
DVT
unlikely” if
Wells and the clinical
colleagues : score is <=1
stratifying
patients
into two risk DVT likely” if
categories the
clinical score
>1
D-dimer highly sensitive
(values up to
poor specificity
assays 95%)
to prove VTE

The negative safely


predictive nearly 100%. rule out both
value DVT and PE.

False nflammation,
pregnancy,
Clinical
usefulness :
positive D- malignancy, decrease with
dimer and the elderly. age

prior to
False negative after heparin administering
D-dimer use, heparin to a
patient
 Venous ultrasonography is the investigation of choice in
patients stratified as DVT likely. It is noninvasive, safe,
available, and relatively inexpensive.

compression ultrasound (B-mode


three types imaging only)
of venous
ultrasonography:
duplex ultrasound (B-mode imaging and
Doppler
waveform analysis),

color Doppler imaging


alone.
 Venography is the definitive diagnostic test for DVT, but it is
rarely done because the noninvasive tests (D-dimer and venous
ultrasound) are more appropriate and accurate to perform in
acute DVT episodes
• constant intraluminal filling defect
cardinal • abrupt cutoff of a deep vein
sign

• It is highly sensitive especially in identifying the


location, extent
Advantage • attachment of a clot and also highly specific

• invasive and painful


• exposed to irradiation
major
setback • allergic reaction and renal dysfunction
 The technique is based on measurement of the
rate of change in impedance between two
electrodes on the calf when a venous occlusion
cuff is deflated
 Thisinvestigative modality has high sensitivity
in detecting calf and pelvic DVTs and upper
extremity venous thromboses.

 MRI is the diagnostic test of choice for


uspected iliac vein or inferior vena caval
thrombosis
Mechanical
intermittent graduated
pneumatic compression venous foot
compression stocking pump
(IPC) device (GCS)
Effective pharmacological agents for prophylaxis of DVT.

Unfractionated low-molecular- 1.Fondaparinux


heparin (UFH) weight 2. new oral
heparins directselective
(LMWH) thrombin
factor Xa inhibitors
inhibitors
 UFH or LMWH, or with fondaparinux.
 Thrombolytic therapy
 Vena cava filters
 DVT is a potentially dangerous clinical
condition that can lead to preventable
morbidity and mortality
 A diagnostic pathway involving pretest
probability, D-dimer assay, and venous
ultrasound serves as a more reliable way of
diagnosing DVT.
 Terima Kasih

You might also like